Bonesupport Holding AB (publ) (0RQO.L)

236.00 -7.58 (-3.11%) As of 02:13PM BST. Market open.

Bonesupport Holding AB (publ)

Scheelevägen 19
Lund 223 70
Sweden
46 4 62 86 53 70
https://www.bonesupport.com

Sector(s): 
Industry: 
Full-time employees: 118

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Emil Billbäck	Chief Executive Officer	11.94M	N/A	1970
Mr. Håkan Johansson	Chief Financial Officer	248k	N/A	1963
Mr. Michael Wrang Mortensen	Executive Vice President of Global R&D and Operations	N/A	N/A	1975
Ms. Annelie Aava Vikner	Executive Vice President of Global Marketing	N/A	N/A	1971
Ms. Helena L. Brandt	Executive Vice President of Human Resources	N/A	N/A	1965
Dr. Michael Diefenbeck M.D., Ph.D.	Executive VP of Medical & Clinical Affairs and Chief Medical Officer	N/A	N/A	1974
Mr. Fergus MacLeod	GM & Executive VP of Commercial Operations of EUROW	N/A	N/A	1970
Mr. Michael Roth	GM & Executive VP of Commercial Operations of North America	N/A	N/A	1963

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. The company was founded in 1999 and is headquartered in Lund, Sweden.

Corporate governance

Bonesupport Holding AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.